Literature DB >> 22647261

Selected findings from the Religious Orders Study and Rush Memory and Aging Project.

David A Bennett1, Robert S Wilson, Zoe Arvanitakis, Patricia A Boyle, Leyla de Toledo-Morrell, Julie A Schneider.   

Abstract

The Religious Orders Study and the Rush Memory and Aging Project are both cohort studies of aging and dementia that include organ donation at death. Together, more than 2,700 persons have agreed to annual clinical evaluation and brain donation at death. A subset of participants also participated in a substudy that included ante-mortem imaging. We highlight recent findings that have been highly cited over the past five years. The findings fall into three general categories. The first relates to the neuropathology of probable Alzheimer's disease, mild cognitive impairment, and those without dementia or mild cognitive impairment. The second relates to risk factors for Alzheimer's disease and neuropathology. The third are clinical and imaging studies of mild cognitive impairment. The findings illustrate the range of insights that can be gained into cognitive aging by incorporating neuropathologic indices into well designed, prospective cohort studies.

Entities:  

Mesh:

Year:  2013        PMID: 22647261      PMCID: PMC3434299          DOI: 10.3233/JAD-2012-129007

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  67 in total

1.  Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease.

Authors:  Travis R Stoub; Leyla deToledo-Morrell; Glenn T Stebbins; Sue Leurgans; David A Bennett; Raj C Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

2.  Effect of social networks on 10 year survival in very old Australians: the Australian longitudinal study of aging.

Authors:  Lynne C Giles; Gary F V Glonek; Mary A Luszcz; Gary R Andrews
Journal:  J Epidemiol Community Health       Date:  2005-07       Impact factor: 3.710

3.  Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Authors:  G Li; E B Larson; J A Sonnen; J B Shofer; E C Petrie; A Schantz; E R Peskind; M A Raskind; J C S Breitner; T J Montine
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

4.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.

Authors:  P Fischer; S Jungwirth; S Zehetmayer; S Weissgram; S Hoenigschnabl; E Gelpi; W Krampla; K H Tragl
Journal:  Neurology       Date:  2007-01-23       Impact factor: 9.910

5.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

6.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Authors:  D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

7.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

8.  Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.

Authors:  David A Bennett; Philip L De Jager; Sue E Leurgans; Julie A Schneider
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

Review 9.  An active and socially integrated lifestyle in late life might protect against dementia.

Authors:  Laura Fratiglioni; Stephanie Paillard-Borg; Bengt Winblad
Journal:  Lancet Neurol       Date:  2004-06       Impact factor: 44.182

Review 10.  Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review.

Authors:  Terence C Chua; Wei Wen; Melissa J Slavin; Perminder S Sachdev
Journal:  Curr Opin Neurol       Date:  2008-02       Impact factor: 5.710

View more
  34 in total

1.  Parahippocampal white matter volume predicts Alzheimer's disease risk in cognitively normal old adults.

Authors:  Travis R Stoub; Leyla Detoledo-Morrell; Bradford C Dickerson
Journal:  Neurobiol Aging       Date:  2014-02-18       Impact factor: 4.673

Review 2.  Untangling Genetic Risk for Alzheimer's Disease.

Authors:  Anna A Pimenova; Towfique Raj; Alison M Goate
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

Review 3.  [Resilience to mental disorders in old age].

Authors:  A Fellgiebel
Journal:  Nervenarzt       Date:  2018-07       Impact factor: 1.214

Review 4.  Single-Cell RNA Sequencing: Unraveling the Brain One Cell at a Time.

Authors:  Dimitry Ofengeim; Nikolaos Giagtzoglou; Dann Huh; Chengyu Zou; Junying Yuan
Journal:  Trends Mol Med       Date:  2017-05-10       Impact factor: 11.951

5.  Vascular factors in neurodegenerative diseases: a path towards treatment and prevention.

Authors:  Gustavo C Román; François Boller
Journal:  Funct Neurol       Date:  2014 Apr-Jun

Review 6.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

7.  RNA-Seq investigations of human post-mortem trigeminal ganglia.

Authors:  Danielle M LaPaglia; Matthew R Sapio; Peter D Burbelo; Jean Thierry-Mieg; Danielle Thierry-Mieg; Stephen J Raithel; Christopher E Ramsden; Michael J Iadarola; Andrew J Mannes
Journal:  Cephalalgia       Date:  2017-07-12       Impact factor: 6.292

8.  Brain tocopherols related to Alzheimer's disease neuropathology in humans.

Authors:  Martha Clare Morris; Julie A Schneider; Hong Li; Christy C Tangney; Sukriti Nag; David A Bennett; William G Honer; Lisa L Barnes
Journal:  Alzheimers Dement       Date:  2014-02-28       Impact factor: 21.566

9.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

Review 10.  The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism.

Authors:  Hans-Ulrich Klein; David A Bennett; Philip L De Jager
Journal:  Acta Neuropathol       Date:  2016-08-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.